The latest study of breast cancer survivors suggests that breast cancer is a “social ecological” disease.
In a new study published in the New England Journal of Medicine, the authors looked at the impact of chemotherapy on the survival of about 100,000 breast cancer patients and found that the patients were generally much more likely to survive than the average.
Researchers compared the survival rate of breast cancers between patients who were treated with chemotherapy and those who received no treatment at all.
The researchers say that the “social environmental model” for breast cancers offers a “more holistic understanding of how to treat the disease and how to manage its effects,” such as chemotherapy, radiation and other treatments.
According to the study, breast cancer “has evolved into a social environmental disease.”
“There is a lot of work to be done,” said Dr. Christopher Fishel, a breast cancer researcher and professor of pediatrics at the University of Toronto who was not involved in the study.
“The social environmental model has been very helpful in understanding breast cancer and how it evolves over time.
But the social ecological model has also had limitations and shortcomings.
This study shows that the social environmental theory has some significant limitations, and it may not be as helpful as some of the research in this area.”
Dr. Fishell said that he would like to see more research that takes the social and environmental aspects of breast disease into account, but he says that is the task at hand.
“We can’t assume that all cancers are the same.
There are many cancers that have different features that are different from those that are the most common,” he said.
The study also found that chemotherapy was associated with increased risk of death and other outcomes.
Researchers analyzed data from the National Breast Screening Program, which has been in place since 1982.
Since the 1970s, more than 2.7 million women have been screened for breast-cancer and more than 1,400 women have died of breast-invasive breast cancer, according to the National Cancer Institute.
The number of new cases has fallen to less than 100 a year, but the number of women dying of breast invasive cancer is on the rise.
The new study was led by researchers from Harvard University, the Johns Hopkins University and the University at Buffalo.
They used data from more than 700,000 women who received breast cancer screenings between 1989 and 2005.
Those who were screened were followed for more than a decade.
Researchers then followed up those women over time to determine whether their breast cancer was diagnosed or not.
The women who were diagnosed with breast cancer were followed up to determine if they survived more than two years after they were diagnosed.
The analysis of the data shows that patients who received chemotherapy were much more often than the general population who did not receive chemotherapy.
Researchers also found a higher rate of death among those who did receive chemotherapy, and this was associated more with the type of chemotherapy than with the dose.
“There are many different cancers that are a combination of different features, and we know that cancer is one of those features,” said lead author Dr. David J. Zuckerman, a professor of radiology and of pediatric oncology at the Johns Wayne University School of Medicine.
“So there are multiple ways in which this cancer evolves.”
Dr Fisheimer said that while it is “an exciting result,” it does not prove that chemotherapy is effective for breast tumors.
He noted that other studies have shown that some types of radiation are linked to increased risk for breast tumor survival.
He said that further research is needed to examine the possible link between chemotherapy and cancer.
“I think there are many unanswered questions, and the data is still evolving,” he told MedPage Today.
“In the meantime, we need to do better and find out what the long-term effects of this are.”